Biomarker development for presymptomatic molecular diagnosis of preeclampsia: Feasible, useful or even unnecessary?

Hahn, S. and Lapaire, O. and Than, Nándor Gábor (2015) Biomarker development for presymptomatic molecular diagnosis of preeclampsia: Feasible, useful or even unnecessary? EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 15 (5). pp. 617-629. ISSN 1473-7159

Preview

Text Hahn2015Biomarker_developmentfor_1_u.pdf Download (393kB) | Preview

Abstract

The past decade saw the advent of a number of promising biomarkers to detect pregnancies at risk for preeclampsia (PE), the foremost being those associated with an imbalance of angiogenic factors. In late pregnancy, these are useful for the detection of imminent cases of PE, while earlier they were more predictive for early- than late-onset PE. This suggests that there may be fundamental differences between the underlying pathology of these two PE forms. Therefore, it is possible that such a biological premise may limit the development of biomarkers that will permit the efficacious detection of both early- and late-onset PE via an analysis of first-trimester maternal blood samples. Consequently, a significant increase in our understanding of the underlying pathology of PE, using a variety of approaches ranging from systems biology to animal models, will be necessary in order to overcome this obstacle. © Informa UK, Ltd.

Actions (login required)

Edit Item